🇺🇸 FDA
Pipeline program

recombinant human thrombopoietin injection

3SBio-TPO-106-Ib-01

Phase 1 small_molecule active

Quick answer

recombinant human thrombopoietin injection for Liver Disease Chronic is a Phase 1 program (small_molecule) at Sunshine Biopharma with 1 ClinicalTrials.gov record(s).

Program details

Company
Sunshine Biopharma
Indication
Liver Disease Chronic
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials